Lactose (India) Ltd | 160 Cr. | 127 | 247/84.3 | 36.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.63 Cr. | 1.90 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,147 Cr. | 381 | 411/192 | 93.0 | 22.8 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 29.8 Cr. | 40.2 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 29.4 Cr. | 20.0 | 29.1/17.0 | 30.6 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 65.7 Cr. | 87.3 | 144/79.0 | 17.3 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 59,248 Cr. | 2,100 | 2,286/1,275 | 44.4 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 269 Cr. | 11.8 | 29.0/10.8 | 16.3 | 8.21 | 0.00 % | 12.5 % | 9.09 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 567 Cr. | 1,201 | 1,340/635 | 24.2 | 299 | 0.06 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 116 Cr. | 23.2 | 32.0/15.0 | 35.6 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,057 Cr. | 359 | 449/219 | 10.1 | 123 | 0.69 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 5.35 Cr. | 25.5 | 39.0/22.8 | 41.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 8.34 Cr. | 3.35 | 9.28/2.11 | 92.6 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 418 Cr. | 430 | 477/112 | 67.2 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,961 Cr. | 1,140 | 1,584/1,078 | 48.3 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 143 Cr. | 0.70 | 1.24/0.48 | 9.41 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 52.9 Cr. | 22.0 | 26.3/6.40 | 54.5 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.8 Cr. | 10.7 | 18.3/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 188 Cr. | 528 | 961/443 | 10.2 | 563 | 0.28 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 70.4 Cr. | 70.4 | 71.0/26.1 | 180 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 19.1 Cr. | 41.7 | 88.7/37.9 | 39.7 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 10.2 Cr. | 4.10 | 5.88/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.0 Cr. | 120 | 154/59.6 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 23.8 Cr. | 43.5 | 45.4/8.57 | 264 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 33.2 Cr. | 44.0 | 80.0/0.00 | 46.8 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 6.55 Cr. | 21.8 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 12,351 Cr. | 712 | 1,028/464 | 34.5 | 65.3 | 0.17 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 95.0 Cr. | 22.0 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.2 Cr. | 24.0 | 46.0/17.4 | 52.9 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 226 Cr. | 393 | 427/241 | 23.7 | 119 | 1.14 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 45.3 Cr. | 31.6 | 62.6/24.0 | 40.8 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 64,251 Cr. | 1,097 | 1,568/994 | 18.9 | 557 | 0.41 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 151 Cr. | 242 | 303/170 | 218 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 882 Cr. | 88.0 | 123/74.0 | 19.1 | 32.5 | 1.69 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 47.0 Cr. | 36.0 | 56.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 11,945 Cr. | 1,459 | 1,530/727 | 63.2 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.62 Cr. | 0.70 | 1.45/0.66 | 92.4 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 240 Cr. | 31.3 | 68.0/30.0 | 12.7 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 125 Cr. | 5.29 | 6.25/2.82 | 227 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 66,121 Cr. | 31,116 | 37,000/25,260 | 45.5 | 1,992 | 1.54 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,303 Cr. | 916 | 972/550 | 31.2 | 220 | 0.53 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 207 Cr. | 72.8 | 75.7/31.3 | 49.7 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,475 Cr. | 1,476 | 1,555/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 25,106 Cr. | 1,543 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 824 Cr. | 251 | 330/154 | 19.2 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 574 Cr. | 429 | 568/270 | 12.3 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,556 Cr. | 505 | 950/483 | 28.5 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,674 Cr. | 1,185 | 1,770/991 | 24.8 | 754 | 0.85 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,20,092 Cr. | 3,549 | 3,790/2,886 | 59.4 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,158 Cr. | 126 | 317/98.0 | | 43.7 | 0.41 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,692 Cr. | 18.0 | 25.2/14.1 | 29.7 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 37,947 Cr. | 992 | 1,360/856 | 108 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 5,225 Cr. | 230 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,84,781 Cr. | 1,604 | 1,960/1,553 | 33.6 | 301 | 1.00 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 3,037 Cr. | 686 | 886/441 | 124 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,589 Cr. | 292 | 398/175 | 36.9 | 75.9 | 0.15 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 372 Cr. | 1,230 | 1,690/956 | 21.5 | 650 | 0.12 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 8,150 Cr. | 833 | 1,003/530 | 63.4 | 243 | 0.12 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 4,599 Cr. | 184 | 241/111 | 152 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 11,632 Cr. | 5,051 | 7,400/4,146 | 32.6 | 340 | 2.32 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,960 Cr. | 2,394 | 2,977/1,772 | 38.2 | 321 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,364 Cr. | 6,244 | 6,739/4,863 | 34.5 | 323 | 2.00 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 204 Cr. | 57.8 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 23,912 Cr. | 5,227 | 6,150/3,701 | 35.4 | 922 | 0.67 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 134 Cr. | 109 | 348/81.0 | 9.44 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,605 Cr. | 425 | 582/259 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,605 Cr. | 711 | 1,998/604 | 42.3 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,591 Cr. | 16,049 | 18,100/10,060 | 156 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 354 Cr. | 15.8 | 53.0/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,443 Cr. | 862 | 1,595/660 | 9.10 | 425 | 0.70 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,978 Cr. | 54.4 | 94.5/41.7 | 32.1 | 21.1 | 0.37 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 7,837 Cr. | 173 | 359/165 | 22.4 | 54.4 | 0.46 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 119 Cr. | 75.2 | 142/65.5 | | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 355 Cr. | 99.3 | 177/90.2 | 47.3 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 93,333 Cr. | 2,043 | 2,403/1,774 | 25.2 | 377 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,110 Cr. | 554 | 980/499 | 12.9 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 48,371 Cr. | 896 | 923/423 | 94.9 | 84.6 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,025 Cr. | 988 | 1,235/596 | 23.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 162 Cr. | 75.4 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 860 Cr. | 178 | 358/154 | 24.6 | 107 | 1.68 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 629 Cr. | 360 | 500/265 | 22.5 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,866 Cr. | 1,122 | 1,310/802 | 36.8 | 393 | 0.45 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,296 Cr. | 1,679 | 1,998/1,303 | 38.4 | 221 | 0.92 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,663 Cr. | 250 | 328/152 | 39.0 | 36.1 | 1.00 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,244 Cr. | 1,310 | 1,758/1,168 | 37.2 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 3,511 Cr. | 120 | 123/57.5 | 33.4 | 57.5 | 0.67 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 765 Cr. | 106 | 149/67.2 | 34.7 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,710 Cr. | 294 | 384/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,195 Cr. | 259 | 465/245 | 50.5 | 102 | 0.54 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,742 Cr. | 2,042 | 2,786/1,243 | 46.3 | 369 | 0.34 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,645 Cr. | 364 | 504/285 | 59.6 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 13,012 Cr. | 536 | 628/412 | 27.3 | 153 | 0.28 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 58,788 Cr. | 2,083 | 2,286/1,275 | 44.1 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,688 Cr. | 2,756 | 3,516/1,921 | 49.3 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 33,637 Cr. | 2,042 | 2,131/1,200 | 29.6 | 592 | 0.90 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,589 Cr. | 466 | 590/359 | 28.2 | 140 | 1.07 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 22,653 Cr. | 1,663 | 1,910/1,097 | 58.5 | 210 | 0.44 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,08,570 Cr. | 1,301 | 1,406/1,020 | 19.1 | 402 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,196 Cr. | 268 | 308/161 | 35.3 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,25,065 Cr. | 1,548 | 1,702/1,310 | 23.2 | 386 | 0.84 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 17,280 Cr. | 2,273 | 2,641/1,551 | 30.6 | 375 | 0.26 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 464 Cr. | 157 | 203/95.6 | 228 | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,598 Cr. | 151 | 191/105 | 15.0 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 71.0 Cr. | 43.6 | 88.0/40.4 | 25.4 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 47,897 Cr. | 358 | 406/291 | 132 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,835 Cr. | 1,818 | 2,215/1,430 | 40.1 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 139 Cr. | 87.4 | 141/76.3 | 19.4 | 48.6 | 1.37 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 291 Cr. | 123 | 124/67.8 | 28.9 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,522 Cr. | 9,009 | 10,691/6,220 | 107 | 308 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,199 Cr. | 760 | 843/544 | 40.3 | 113 | 0.60 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 199 Cr. | 94.5 | 145/85.0 | 7.55 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 65,767 Cr. | 5,500 | 6,440/4,492 | 28.9 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 19,069 Cr. | 970 | 1,304/725 | 32.2 | 264 | 1.13 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 461 Cr. | 808 | 1,540/763 | 73.3 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 31,854 Cr. | 2,550 | 3,464/2,022 | 34.2 | 303 | 1.10 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,852 Cr. | 344 | 560/258 | 28.1 | 127 | 1.51 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,676 Cr. | 509 | 575/312 | 26.1 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 19,025.50 Cr | 1,202.60 | | 51.03 | 193.71 | 0.32% | 16.40% | 15.13% | 6.18 |